+关注
ecc9ac9
暂无个人介绍
IP属地：未知
3
关注
0
粉丝
0
主题
0
勋章
主贴
热门
ecc9ac9
2021-12-24
What?
Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?
ecc9ac9
2021-12-24
Nice
S&P 500 hits record close as Omicron fears ebb
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3582280425444565,"uuid":"3582280425444565","gmtCreate":1619189883494,"gmtModify":1619189883494,"name":"ecc9ac9","pinyin":"llx88","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":698199937,"gmtCreate":1640313639075,"gmtModify":1640313862934,"author":{"id":"3582280425444565","authorId":"3582280425444565","name":"ecc9ac9","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"What?","listText":"What?","text":"What?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698199937","repostId":"1128727196","repostType":4,"repost":{"id":"1128727196","pubTimestamp":1640305733,"share":"https://www.laohu8.com/m/news/1128727196?lang=&edition=full","pubTime":"2021-12-24 08:28","market":"us","language":"en","title":"Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=1128727196","media":"Motley Fool","summary":"These electric vehicle stocks are on sale, but that doesn't mean all are buys.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>Lucid and Rivian are unproven but have a lot of potential.</li>\n <li>Nio is down big from its high but just gave investors a jolt on Nio Day.</li>\n <li>Tesla has a high valuation but is in its best shape ever.</li>\n</ul>\n<p>December has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many growth stocks are actually down a lot for the year, and some are close to their 52-week lows.</p>\n<p><b>Lucid Group</b>(NASDAQ:LCID),<b>Rivian Automotive</b>(NASDAQ:RIVN),<b>Nio</b>(NYSE:NIO), and <b>Tesla</b>(NASDAQ:TSLA) are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a625e7f56da175a14e5d6cbfcdce47c\" tg-width=\"2000\" tg-height=\"1000\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: NIO.</span></p>\n<p><b>Lucid has some serious upside</b></p>\n<p>Share prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid delivered on its promises in 2021 by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents that was issued on Dec. 3 and a controversial senior note offering, have taken a toll on Lucid stock of late.</p>\n<p>Despite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a staple in the luxury sedan market over time.</p>\n<p><b>Rivian isn't worth $86 billion...yet</b></p>\n<p>Rivian has seen its stock sink as the honeymoon period after its initial public offering (IPO) draws to a close. In fact, Rivian's share price fell over 10% on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.</p>\n<p><b>Down but not out</b></p>\n<p>No stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3055b147aea5ec316e8f30352bbd489d\" tg-width=\"720\" tg-height=\"516\" width=\"100%\" height=\"auto\"><span>LCID DATA BY YCHARTS</span></p>\n<p>It wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.</p>\n<p>Nio has been mass-producing electric cars for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an uncertain growth plan in Europe are all headwinds facing Nio right now. What's more, the SEC is tightening its grip on foreign companies like Nio.</p>\n<p>However, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.</p>\n<p><b>Firing on all electric motors</b></p>\n<p>Tesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.</p>\n<p>Despite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are reasons to like the company for years to come.</p>\n<p><b>An EV basket for 2022</b></p>\n<p>Two ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a 50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.</p>\n<p>However, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDown Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 08:28 GMT+8 <a href=https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nLucid and Rivian are unproven but have a lot of potential.\nNio is down big from its high but just gave investors a jolt on Nio Day.\nTesla has a high valuation but is in its best shape ever...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc","NIO":"蔚来","RIVN":"Rivian Automotive, Inc.","TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128727196","content_text":"Key Points\n\nLucid and Rivian are unproven but have a lot of potential.\nNio is down big from its high but just gave investors a jolt on Nio Day.\nTesla has a high valuation but is in its best shape ever.\n\nDecember has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many growth stocks are actually down a lot for the year, and some are close to their 52-week lows.\nLucid Group(NASDAQ:LCID),Rivian Automotive(NASDAQ:RIVN),Nio(NYSE:NIO), and Tesla(NASDAQ:TSLA) are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.\nIMAGE SOURCE: NIO.\nLucid has some serious upside\nShare prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid delivered on its promises in 2021 by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents that was issued on Dec. 3 and a controversial senior note offering, have taken a toll on Lucid stock of late.\nDespite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a staple in the luxury sedan market over time.\nRivian isn't worth $86 billion...yet\nRivian has seen its stock sink as the honeymoon period after its initial public offering (IPO) draws to a close. In fact, Rivian's share price fell over 10% on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.\nDown but not out\nNo stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.\nLCID DATA BY YCHARTS\nIt wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.\nNio has been mass-producing electric cars for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an uncertain growth plan in Europe are all headwinds facing Nio right now. What's more, the SEC is tightening its grip on foreign companies like Nio.\nHowever, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.\nFiring on all electric motors\nTesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.\nDespite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are reasons to like the company for years to come.\nAn EV basket for 2022\nTwo ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a 50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.\nHowever, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.","news_type":1},"isVote":1,"tweetType":1,"viewCount":338,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698108900,"gmtCreate":1640312610605,"gmtModify":1640313775859,"author":{"id":"3582280425444565","authorId":"3582280425444565","name":"ecc9ac9","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698108900","repostId":"2193078140","repostType":4,"repost":{"id":"2193078140","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640299360,"share":"https://www.laohu8.com/m/news/2193078140?lang=&edition=full","pubTime":"2021-12-24 06:42","market":"us","language":"en","title":"S&P 500 hits record close as Omicron fears ebb","url":"https://stock-news.laohu8.com/highlight/detail?id=2193078140","media":"Reuters","summary":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* ","content":"<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a> and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.</p>\n<p>The S&P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 hits record close as Omicron fears ebb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 hits record close as Omicron fears ebb\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 06:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a> and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.</p>\n<p>The S&P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SH":"标普500反向ETF","SSO":"两倍做多标普500ETF","BK4534":"瑞士信贷持仓","SPXU":"三倍做空标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","OEX":"标普100",".SPX":"S&P 500 Index","SPY":"标普500ETF","BK4559":"巴菲特持仓","IVV":"标普500指数ETF","BK4550":"红杉资本持仓","OEF":"标普100指数ETF-iShares","UPRO":"三倍做多标普500ETF","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193078140","content_text":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* Weekly jobless claims unchanged at 205,000\n* Consumer spending increases 0.6% in November\n* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%\nDec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.\nStocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.\nVaccine makers AstraZeneca Plc and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.\nThe arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.\n“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\nThe Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.\nDefensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.\nThe S&P 500 has gained for three days, after falling in the three prior sessions.\n“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.\nFor the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.\nTrading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.\nIn another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.\nThe number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.\nTesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.\nThe S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.\nThe S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.\nAbout 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":698108900,"gmtCreate":1640312610605,"gmtModify":1640313775859,"author":{"id":"3582280425444565","authorId":"3582280425444565","name":"ecc9ac9","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698108900","repostId":"2193078140","repostType":4,"repost":{"id":"2193078140","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640299360,"share":"https://www.laohu8.com/m/news/2193078140?lang=&edition=full","pubTime":"2021-12-24 06:42","market":"us","language":"en","title":"S&P 500 hits record close as Omicron fears ebb","url":"https://stock-news.laohu8.com/highlight/detail?id=2193078140","media":"Reuters","summary":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* ","content":"<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a> and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.</p>\n<p>The S&P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 hits record close as Omicron fears ebb</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 hits record close as Omicron fears ebb\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 06:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Major indexes climb for 3rd straight session</p>\n<p>* Merck's at-home COVID-19 pill gets U.S. approval</p>\n<p>* Weekly jobless claims unchanged at 205,000</p>\n<p>* Consumer spending increases 0.6% in November</p>\n<p>* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%</p>\n<p>Dec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.</p>\n<p>Stocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.</p>\n<p>Vaccine makers <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a> and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.</p>\n<p>The arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.</p>\n<p>“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.</p>\n<p>The Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.</p>\n<p>Defensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.</p>\n<p>The S&P 500 has gained for three days, after falling in the three prior sessions.</p>\n<p>“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.</p>\n<p>For the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.</p>\n<p>Trading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.</p>\n<p>In another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.</p>\n<p>The number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.</p>\n<p>Tesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.</p>\n<p>The S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.</p>\n<p>The S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.</p>\n<p>About 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","SH":"标普500反向ETF","SSO":"两倍做多标普500ETF","BK4534":"瑞士信贷持仓","SPXU":"三倍做空标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","OEX":"标普100",".SPX":"S&P 500 Index","SPY":"标普500ETF","BK4559":"巴菲特持仓","IVV":"标普500指数ETF","BK4550":"红杉资本持仓","OEF":"标普100指数ETF-iShares","UPRO":"三倍做多标普500ETF","BK4504":"桥水持仓","SDS":"两倍做空标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193078140","content_text":"* Major indexes climb for 3rd straight session\n* Merck's at-home COVID-19 pill gets U.S. approval\n* Weekly jobless claims unchanged at 205,000\n* Consumer spending increases 0.6% in November\n* Indexes up: Dow 0.55%, S&P 0.62%, Nasdaq 0.85%\nDec 23 (Reuters) - Wall Street's main indexes posted solid gains for a third straight session on Thursday, with the S&P 500 marking a record-high close, as encouraging developments gave investors more ease about the economic impact of the Omicron coronavirus variant.\nStocks ended the holiday-shortened week on a positive note, lifting sentiment heading into Christmas. Gains were broad among S&P 500 sectors, led by consumer discretionary and industrials, which both rose about 1.2%.\nVaccine makers AstraZeneca Plc and Novavax Inc said their shots protected against Omicron as UK data suggested it may cause proportionally fewer hospital cases than the Delta variant, though public health experts warned the battle against COVID-19 was far from over.\nThe arrival of Omicron has helped ratchet up market volatility for much of the last month of 2021, which has been a strong year for equities.\n“There was a lot of negative sentiment coming into the final part of the year, and investors have likely continued to see pretty strong economic growth and pretty positive developments as it relates to healthcare innovation around COVID and that is putting in a bit of a bid into equities and causing investors to look to allocate capital as they close out the year,” said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.\nThe Dow Jones Industrial Average rose 196.67 points, or 0.55%, to 35,950.56, the S&P 500 gained 29.23 points, or 0.62%, to 4,725.79 and the Nasdaq Composite added 131.48 points, or 0.85%, to 15,653.37.\nDefensive sectors, which have mostly outperformed in December, generally lagged on Thursday. The real estate sector fell 0.4%.\nThe S&P 500 has gained for three days, after falling in the three prior sessions.\n“People are seeing the strength on Tuesday and Wednesday and all of a sudden everybody is more optimistic again,” said Robert Pavlik, senior portfolio manager at Dakota Wealth Management.\nFor the week, the S&P 500 rose 2.3%, the Dow gained about 1.7% and the Nasdaq climbed 3.2%.\nTrading volumes were expected to be thinner than usual ahead of the Christmas and New Year holidays. The stock market will be closed on Friday in observance of the Christmas holiday.\nIn another medical development against the pandemic, the United States authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc. Merck shares fell 0.6%, while Pfizer dropped 1.4%.\nThe number of Americans filing new claims for unemployment benefits held below pre-pandemic levels last week as the labor market tightens, while consumer spending increased solidly, putting the economy on track for a strong finish to 2021.\nTesla Inc shares rose 5.8%, gaining sharply for a second day after Chief Executive Elon Musk said on Wednesday he was \"almost done\" with his stock sales after selling over $15 billion worth since early November.\nThe S&P 500 is up about 26% so far this year. Still, the environment for equities could be changing heading into next year as the Federal Reserve is expected to begin raising interest rates in 2022.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.40-to-1 ratio; on Nasdaq, a 2.22-to-1 ratio favored advancers.\nThe S&P 500 posted 35 new 52-week highs and no new lows; the Nasdaq Composite recorded 62 new highs and 80 new lows.\nAbout 8 billion shares changed hands in U.S. exchanges, compared with the 11.8 billion daily average over the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698199937,"gmtCreate":1640313639075,"gmtModify":1640313862934,"author":{"id":"3582280425444565","authorId":"3582280425444565","name":"ecc9ac9","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"What?","listText":"What?","text":"What?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698199937","repostId":"1128727196","repostType":4,"repost":{"id":"1128727196","pubTimestamp":1640305733,"share":"https://www.laohu8.com/m/news/1128727196?lang=&edition=full","pubTime":"2021-12-24 08:28","market":"us","language":"en","title":"Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=1128727196","media":"Motley Fool","summary":"These electric vehicle stocks are on sale, but that doesn't mean all are buys.","content":"<p><b>Key Points</b></p>\n<ul>\n <li>Lucid and Rivian are unproven but have a lot of potential.</li>\n <li>Nio is down big from its high but just gave investors a jolt on Nio Day.</li>\n <li>Tesla has a high valuation but is in its best shape ever.</li>\n</ul>\n<p>December has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many growth stocks are actually down a lot for the year, and some are close to their 52-week lows.</p>\n<p><b>Lucid Group</b>(NASDAQ:LCID),<b>Rivian Automotive</b>(NASDAQ:RIVN),<b>Nio</b>(NYSE:NIO), and <b>Tesla</b>(NASDAQ:TSLA) are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4a625e7f56da175a14e5d6cbfcdce47c\" tg-width=\"2000\" tg-height=\"1000\" width=\"100%\" height=\"auto\"><span>IMAGE SOURCE: NIO.</span></p>\n<p><b>Lucid has some serious upside</b></p>\n<p>Share prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid delivered on its promises in 2021 by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents that was issued on Dec. 3 and a controversial senior note offering, have taken a toll on Lucid stock of late.</p>\n<p>Despite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a staple in the luxury sedan market over time.</p>\n<p><b>Rivian isn't worth $86 billion...yet</b></p>\n<p>Rivian has seen its stock sink as the honeymoon period after its initial public offering (IPO) draws to a close. In fact, Rivian's share price fell over 10% on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.</p>\n<p><b>Down but not out</b></p>\n<p>No stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3055b147aea5ec316e8f30352bbd489d\" tg-width=\"720\" tg-height=\"516\" width=\"100%\" height=\"auto\"><span>LCID DATA BY YCHARTS</span></p>\n<p>It wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.</p>\n<p>Nio has been mass-producing electric cars for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an uncertain growth plan in Europe are all headwinds facing Nio right now. What's more, the SEC is tightening its grip on foreign companies like Nio.</p>\n<p>However, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.</p>\n<p><b>Firing on all electric motors</b></p>\n<p>Tesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.</p>\n<p>Despite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are reasons to like the company for years to come.</p>\n<p><b>An EV basket for 2022</b></p>\n<p>Two ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a 50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.</p>\n<p>However, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Down Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDown Over 25% From Their Highs, Are Lucid, Rivian, Nio, and Tesla Buys for 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 08:28 GMT+8 <a href=https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nLucid and Rivian are unproven but have a lot of potential.\nNio is down big from its high but just gave investors a jolt on Nio Day.\nTesla has a high valuation but is in its best shape ever...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LCID":"Lucid Group Inc","NIO":"蔚来","RIVN":"Rivian Automotive, Inc.","TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/12/23/down-over-25-from-their-highs-are-lucid-rivian-nio/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128727196","content_text":"Key Points\n\nLucid and Rivian are unproven but have a lot of potential.\nNio is down big from its high but just gave investors a jolt on Nio Day.\nTesla has a high valuation but is in its best shape ever.\n\nDecember has so far been a wild month as the major indices routinely make big moves each day. While some stocks are hovering around their all-time highs, many growth stocks are actually down a lot for the year, and some are close to their 52-week lows.\nLucid Group(NASDAQ:LCID),Rivian Automotive(NASDAQ:RIVN),Nio(NYSE:NIO), and Tesla(NASDAQ:TSLA) are four high-profile electric vehicle (EV) stocks that are all down 25% or more from their highs. Here's the lowdown on each, as well as the best one to buy now.\nIMAGE SOURCE: NIO.\nLucid has some serious upside\nShare prices of Lucid Group are down 38% from their high as the up-and-coming electric sedan company faces what should be a challenging 2022. Lucid delivered on its promises in 2021 by expanding its manufacturing facility, going public and raising cash, entering mass production, and starting customer deliveries. Yet recent events, most notably a U.S. Securities and Exchange Commission (SEC) request for documents that was issued on Dec. 3 and a controversial senior note offering, have taken a toll on Lucid stock of late.\nDespite the bad press, there's reason to believe Lucid could be a great stock to own over the long term. The timing of the senior note offering was fantastic for Lucid, which valued its stock at $54.78 per share (a 37% premium to its share price at the time of this writing). It also gives the company the cash needed to accelerate production, expand manufacturing capacity, and meet a customer demand that currently sits at over 17,000 reservations. Given its incredible battery technology, Lucid could become a staple in the luxury sedan market over time.\nRivian isn't worth $86 billion...yet\nRivian has seen its stock sink as the honeymoon period after its initial public offering (IPO) draws to a close. In fact, Rivian's share price fell over 10% on Dec. 17 after the company reported its Q3 2021 earnings, which was its first report as a public company. Lower-than-expected customer deliveries, wider-than-expected losses, and the harsh reality that it's going to take a lot of money to grow its manufacturing and charging network to the size Rivian hopes added up to an overall disappointing quarter. However, Rivian's reservation numbers are growing at a breakneck pace -- quite a bit faster than Lucid's, in fact. However, until Rivian is able to set goals and then meet or exceed them, it's hard to trust the company's trajectory, let alone value Rivian at $86 billion.\nDown but not out\nNo stock on this list is further off its high than Chinese automaker Nio, which got gut-punched with a 55% drawdown and is now hovering right around its 52-week low.\nLCID DATA BY YCHARTS\nIt wasn't long ago that Nio was getting the same buzz Lucid and Rivian have received the last few months. But lately, it's found itself outside the limelight, or briefly in it for negative reasons.\nNio has been mass-producing electric cars for a few years now and is becoming an established player in the space.Inconsistent production numbers, and an uncertain growth plan in Europe are all headwinds facing Nio right now. What's more, the SEC is tightening its grip on foreign companies like Nio.\nHowever, Nio held its highly anticipated Nio Day on Dec. 18, unveiling its new ET5 midsize sedan and making various announcements. Nio is showing no shortage of innovation and could be a great long-term winner.\nFiring on all electric motors\nTesla is down \"just\" 25% from its high as investors grapple with valuation concerns for many growth stocks. Tesla isn't the same unprofitable and streaky company it once was, but it is priced to perfection at a 22.5 price-to-sales (P/S) ratio and a 301.8 price-to-earnings (P/E) ratio.\nDespite the sky-high valuation,there's a lot to like about Tesla the company. Its industry-leading operating margin, impressive growth, diverse business, and market-leading position in the growing EV industry are reasons to like the company for years to come.\nAn EV basket for 2022\nTwo ways to approach the sell-off in top-tier EV stocks are the basket strategy and the wait-and-see strategy. Investing in, say, a 50/50 split of Lucid and Tesla, or even an equal split of all four companies on this list, gives exposure to multiple aspects of the market while limiting the damage any single company can inflict on your portfolio.\nHowever, there's a good chance that we are years away from consistent profitability from Lucid, Rivian, or Nio. For many investors, simply waiting for the EV space to mature and then picking a winner may leave some money on the table, but it could be a safer and still rewarding bet.","news_type":1},"isVote":1,"tweetType":1,"viewCount":338,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
